Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 32, 2021 - Issue 7
Submit an article Journal homepage
2,502
Views
2
CrossRef citations to date
0
Altmetric
Psoriasis and atopic dermatitis

Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase 3 trials

Steven R. Feldmana Department of Dermatology, Department of Pathology, Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USACorrespondence[email protected]
View further author information
,
Braulio Gomezb Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
,
Xiangyi Mengb Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
&
Rebecca Germinob Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
Pages 709-715 | Received 10 Dec 2019, Accepted 19 Dec 2019, Published online: 03 Jan 2020

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.